Events & Presentations

Date	Event Details	Remind Me
Feb 4, 2021 4:30 PM EST	Arrowhead Pharmaceuticals 2021 First Quarter Results Listen to webcast	Add to Outlook Add to Google Calendar

Date	Event Details
May 23, 2019 8:30 AM PDT	20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference Listen to webcast Location: Beverly Hills View Additional Information Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
May 18, 2019 11:25 AM EDT	2019 National Lipid Association Scientific Sessions Supporting Materials: View Presentation 948.9 KB Location: Aventura, FL View Additional Information So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3”
May 15, 2019 8:40 AM PDT	Bank of America Merrill Lynch 2019 Health Care Conference Listen to webcast Location: Las Vegas, Nevada View Additional Information Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
May 15, 2019 11:00 AM EDT	Vascular Discovery: From Genes to Medicine 2019 Scientific Sessions (ATVB\|PVD) Supporting Materials: View Presentation 3 MB Location: Boston View Additional Information So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis”
May 8, 2019 4:30 PM EDT	Arrowhead Pharmaceuticals 2019 Second Quarter Results Listen to webcast
Apr 10, 2019	The EASL International Liver Congress 2019 Supporting Materials: View Presentation 3.8 MB View Presentation 3.5 MB View Additional Information Oral Presentation: Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg <100 IU/mL threshold Presentation Reference: PS-080 Session: Parallel session: Hepatitis B - drug development Date and Time: April 12, 2019 at 5:45 p.m. CET Authors: Man-Fung Yuen, et al. Poster Presentation: Reduction of hepatic Z-alpha1 antitrypsin by RNA interference (RNAi) prevents and reverses liver disease including hepatic mitochondrial injury in the PiZ mouse model Presentation Reference: FRI-446 Session: Poster: Rare liver diseases (including pediatric and genetic) Session Date and Time: April 12, 2019 from 9 a.m. to 5 p.m. CET Authors: Christine Wooddell, et al.
Apr 3, 2019 8:00 AM EDT	AACR Annual Meeting 2019 Supporting Materials: View Presentation 10.8 MB View Additional Information So Wong, Ph.D., Arrowhead’s director of oncology, will deliver a poster presentation titled, “Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma”
Mar 27 - Mar 30, 2019	CSHL Meeting: RNA & Oligonucleotide Therapeutics Supporting Materials: View Presentation 11.5 MB Location: Cold Spring Harbor, NY View Additional Information Dr. Hamilton will deliver an oral presentation titled, “Cardiovascular and lipid disorders - A next frontier for TRiMTM RNAi”
Mar 26, 2019 4:35 PM EDT	Oligonucleotide & Precision Therapeutics (OPT) Congress Supporting Materials: View Presentation 11.5 MB Location: Cambridge, MA View Additional Information James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
Mar 18, 2019 9:30 AM EDT	Jefferies HBV Investor Summit Listen to webcast Location: New York View Additional Information Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst